Craft

Shandong Xinhua Pharmaceutical

Stock Price

¥16.2

2024-10-29

Market Capitalization

¥8.8 B

2024-10-29

Revenue

¥8.6 B

FY, 2025

Shandong Xinhua Pharmaceutical Summary

Company Summary

Overview
Shandong Xinhua Pharmaceutical (山東新華製藥股份有限公司) is a healthcare company that produces antipyretic and analgesic drugs. It develops drugs to cover various therapeutic areas such as central nervous, cardio-cerebrovascular systems, and steroids. The company offers medicines in dosage forms of injections, tablets, capsules, etc.
Type
Public
Status
Active
Founded
1943
HQ
Zibo, CN | view all locations
Website
http://xhzy.com
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Zibo, Shan Dong Sheng HQ

    China

    No. 1, Lutai Avenue, High-tech Zone

Shandong Xinhua Pharmaceutical Financials

Summary Financials

Revenue (Q1, 2026)
¥2.4B
Gross profit (Q1, 2026)
¥418.2M
Net income (Q1, 2026)
¥83.3M
Cash (Q1, 2026)
¥1.3B
EBIT (Q1, 2026)
¥133.1M
Enterprise value
$9.5B

Footer menu